VCYT insider transactions

EVP, General Counsel Mcguire Annie sold $158,036 worth of shares (3,176 units at $49.76) as part of a pre-agreed trading plan and covered exercise/tax liability with 3,292 shares, decreasing direct ownership by 5% to 137,240 units (SEC Form 4) to satisfy withholding obligation

VP, Chief Accounting Officer Wygant Jonathan covered exercise/tax liability with 1,361 shares, decreasing direct ownership by 3% to 44,073 units (SEC Form 4) to satisfy withholding obligation

Chief Financial Officer Chambers Rebecca covered exercise/tax liability with 3,693 shares and sold $177,083 worth of shares (3,561 units at $49.73) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 173,280 units (SEC Form 4) (withholding obligation)

Chief Scientific & Med Officer Febbo Phillip G. covered exercise/tax liability with 3,730 shares, decreasing direct ownership by 2% to 149,797 units (SEC Form 4) to cover taxes

Chief Executive Officer Stapley Marc covered exercise/tax liability with 9,012 shares, exercised 138,051 shares at a strike of $36.60 and sold $6,919,585 worth of shares (138,051 units at $50.12) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 440,494 units (SEC Form 4) (tax withholding)

Global Chief Commercial Off Leite John sold $699,732 worth of shares (13,975 units at $50.07) as part of a pre-agreed trading plan and covered exercise/tax liability with 4,059 shares, decreasing direct ownership by 12% to 132,305 units (SEC Form 4) (withholding obligation)

VP, Chief Accounting Officer Wygant Jonathan exercised 24,000 shares at a strike of $24.80 and sold $1,089,624 worth of shares (24,000 units at $45.40) (SEC Form 4)

Director Epstein Robert S sold $440,129 worth of shares (10,000 units at $44.01) as part of a pre-agreed trading plan, decreasing direct ownership by 16% to 52,446 units (SEC Form 4)

SVP, General Counsel Mcguire Annie sold $398,211 worth of shares (10,204 units at $39.02) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 143,708 units (SEC Form 4)

SEC Form 4 filed by Haas Kevin Richard

SEC Form 3 filed by new insider Haas Kevin Richard

Chief Financial Officer Chambers Rebecca was granted 49,338 shares, increasing direct ownership by 38% to 180,534 units (SEC Form 4)

SEC Form 4 filed by Veracyte Inc.

Chief Scientific & Med Officer Febbo Phillip G. was granted 36,181 shares, increasing direct ownership by 31% to 153,527 units (SEC Form 4)

SEC Form 4 filed by Veracyte Inc.

SEC Form 4 filed by Veracyte Inc.

VP, Chief Accounting Officer Wygant Jonathan was granted 10,525 shares, increasing direct ownership by 30% to 45,434 units (SEC Form 4)

Chief Executive Officer Stapley Marc sold $1,637,594 worth of shares (45,523 units at $35.97), decreasing direct ownership by 11% to 357,554 units (SEC Form 4)

Chief Financial Officer Chambers Rebecca sold $662,869 worth of shares (18,341 units at $36.14), decreasing direct ownership by 12% to 131,196 units (SEC Form 4)

Chief Commercial Officer-CLIA Leite John sold $185,083 worth of shares (5,260 units at $35.19), decreasing direct ownership by 5% to 107,580 units (SEC Form 4)

SVP, General Counsel Mcguire Annie sold $236,725 worth of shares (6,658 units at $35.55), decreasing direct ownership by 7% to 94,706 units (SEC Form 4)

SVP, General Counsel Mcguire Annie covered exercise/tax liability with 6,902 shares, decreasing direct ownership by 6% to 101,364 units (SEC Form 4)

VP, Chief Accounting Officer Wygant Jonathan covered exercise/tax liability with 3,006 shares, decreasing direct ownership by 8% to 34,909 units (SEC Form 4)

Chief Financial Officer Chambers Rebecca covered exercise/tax liability with 7,234 shares, decreasing direct ownership by 5% to 149,537 units (SEC Form 4)

Chief Commercial Officer-CLIA Leite John covered exercise/tax liability with 7,517 shares, decreasing direct ownership by 6% to 112,840 units (SEC Form 4)

Chief Scientific & Med Officer Febbo Phillip G. covered exercise/tax liability with 6,035 shares and sold $485,429 worth of shares (13,425 units at $36.16), decreasing direct ownership by 14% to 117,346 units (SEC Form 4)

Chief Executive Officer Stapley Marc covered exercise/tax liability with 19,455 shares, decreasing direct ownership by 5% to 403,077 units (SEC Form 4)

Chief Commercial Officer-CLIA Leite John was granted 47,149 shares and covered exercise/tax liability with 8,905 shares, increasing direct ownership by 47% to 120,357 units (SEC Form 4)

Chief Executive Officer Stapley Marc was granted 139,074 shares and covered exercise/tax liability with 35,841 shares, increasing direct ownership by 32% to 422,532 units (SEC Form 4)

Chief Financial Officer Chambers Rebecca was granted 59,324 shares and covered exercise/tax liability with 12,049 shares, increasing direct ownership by 43% to 156,771 units (SEC Form 4)

Chief Scientific & Med Officer Febbo Phillip G. was granted 71,806 shares and covered exercise/tax liability with 24,486 shares, increasing direct ownership by 53% to 136,806 units (SEC Form 4)

SVP, General Counsel Mcguire Annie was granted 50,999 shares and covered exercise/tax liability with 10,867 shares, increasing direct ownership by 59% to 108,266 units (SEC Form 4)

SVP, General Counsel Mcguire Annie sold $463,204 worth of shares (10,739 units at $43.13), decreasing direct ownership by 14% to 67,760 units (SEC Form 4)

Director Eastham Karin exercised 20,000 shares at a strike of $7.77 and sold $908,923 worth of shares (20,000 units at $45.45) (SEC Form 4)

Chief Scientific & Med Officer Febbo Phillip G. covered exercise/tax liability with 2,955 shares, decreasing direct ownership by 3% to 89,486 units (SEC Form 4)

SVP, General Counsel Mcguire Annie covered exercise/tax liability with 3,052 shares and sold $67,261 worth of shares (1,422 units at $47.30), decreasing direct ownership by 5% to 78,499 units (SEC Form 4)

Chief Financial Officer Chambers Rebecca covered exercise/tax liability with 3,384 shares and sold $621,955 worth of shares (13,278 units at $46.84), decreasing direct ownership by 13% to 109,496 units (SEC Form 4)

Chief Executive Officer Stapley Marc covered exercise/tax liability with 7,914 shares and sold $361,076 worth of shares (7,668 units at $47.09), decreasing direct ownership by 5% to 318,603 units (SEC Form 4)

Chief Commercial Officer-CLIA Leite John covered exercise/tax liability with 2,900 shares and sold $60,718 worth of shares (1,278 units at $47.51), decreasing direct ownership by 5% to 82,113 units (SEC Form 4)

VP, Chief Accounting Officer Wygant Jonathan covered exercise/tax liability with 1,325 shares, decreasing direct ownership by 3% to 37,420 units (SEC Form 4)

Director Jones Evan/ Fa sold $55,576 worth of shares (1,106 units at $50.25), decreasing direct ownership by 4% to 29,362 units (SEC Form 4)

Chief Commercial Officer-CLIA Leite John sold $140,400 worth of shares (2,808 units at $50.00), decreasing direct ownership by 3% to 86,291 units (SEC Form 4)

Director Holstein Jens sold $423,563 worth of shares (10,000 units at $42.36), decreasing direct ownership by 27% to 27,199 units (SEC Form 4)

VP, Chief Accounting Officer Wygant Jonathan sold $449,907 worth of shares (10,920 units at $41.20), decreasing direct ownership by 22% to 38,745 units (SEC Form 4)

SVP, General Counsel Mcguire Annie sold $258,640 worth of shares (6,466 units at $40.00), decreasing direct ownership by 7% to 82,973 units (SEC Form 4)

Director Jones Evan/ Fa exercised 30,000 shares at a strike of $6.94 and sold $1,946,288 worth of shares (43,196 units at $45.06), decreasing direct ownership by 30% to 30,468 units (SEC Form 4)

Director Eastham Karin sold $387,191 worth of shares (9,674 units at $40.02), decreasing direct ownership by 42% to 13,554 units (SEC Form 4)

Chief Financial Officer Chambers Rebecca sold $287,000 worth of shares (7,000 units at $41.00), decreasing direct ownership by 5% to 126,158 units (SEC Form 4)

VP, Chief Accounting Officer Wygant Jonathan was granted 2,886 shares, increasing direct ownership by 6% to 49,665 units (SEC Form 4)

Chief Scientific & Med Officer Febbo Phillip G. sold $300,709 worth of shares (8,349 units at $36.02), decreasing direct ownership by 8% to 92,441 units (SEC Form 4)

Chief Commercial Officer-CLIA Leite John sold $88,865 worth of shares (2,539 units at $35.00), decreasing direct ownership by 3% to 89,099 units (SEC Form 4)

Director Epstein Robert S exercised 10,000 shares at a strike of $7.94 and sold $753,204 worth of shares (21,473 units at $35.08), decreasing direct ownership by 16% to 62,446 units (SEC Form 4)

SVP, General Counsel Mcguire Annie sold $75,608 worth of shares (2,160 units at $35.00), decreasing direct ownership by 2% to 89,439 units (SEC Form 4)

SVP, General Counsel Mcguire Annie sold $76,920 worth of shares (2,283 units at $33.69), decreasing direct ownership by 2% to 91,599 units (SEC Form 4)

Chief Executive Officer Stapley Marc sold $233,133 worth of shares (7,667 units at $30.41), decreasing direct ownership by 2% to 334,185 units (SEC Form 4)

Chief Financial Officer Chambers Rebecca covered exercise/tax liability with 5,371 shares, decreasing direct ownership by 4% to 133,158 units (SEC Form 4)

SVP, General Counsel Mcguire Annie covered exercise/tax liability with 3,507 shares, decreasing direct ownership by 4% to 93,882 units (SEC Form 4)

Chief Executive Officer Stapley Marc covered exercise/tax liability with 7,914 shares, decreasing direct ownership by 2% to 341,852 units (SEC Form 4)

Chief Scientific & Med Officer Febbo Phillip G. covered exercise/tax liability with 2,955 shares, decreasing direct ownership by 3% to 100,790 units (SEC Form 4)

Chief Commercial Officer-CLIA Leite John covered exercise/tax liability with 2,902 shares, decreasing direct ownership by 3% to 91,638 units (SEC Form 4)